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Abstract
Background: The Protein Ontology (PRO) is designed as a formal and principled Open Biomedical
Ontologies (OBO) Foundry ontology for proteins. The components of PRO extend from a classification of
proteins on the basis of evolutionary relationships at the homeomorphic level to the representation of the
multiple protein forms of a gene, including those resulting from alternative splicing, cleavage and/or post-
translational modifications. Focusing specifically on the TGF-beta signaling proteins, we describe the
building, curation, usage and dissemination of PRO.
Results: PRO is manually curated on the basis of PrePRO, an automatically generated file with content
derived from standard protein data sources. Manual curation ensures that the treatment of the protein
classes and the internal and external relationships conform to the PRO framework. The current release of
PRO is based upon experimental data from mouse and human proteins wherein equivalent protein forms
are represented by single terms. In addition to the PRO ontology, the annotation of PRO terms is released
as a separate PRO association file, which contains, for each given PRO term, an annotation from the
experimentally characterized sub-types as well as the corresponding database identifiers and sequence
coordinates. The annotations are added in the form of relationship to other ontologies. Whenever possible,
equivalent forms in other species are listed to facilitate cross-species comparison. Splice and allelic variants,
gene fusion products and modified protein forms are all represented as entities in the ontology. Therefore,
PRO provides for the representation of protein entities and a resource for describing the associated data.
This makes PRO useful both for proteomics studies where isoforms and modified forms must be
differentiated, and for studies of biological pathways, where representations need to take account of the
different ways in which the cascade of events may depend on specific protein modifications.
Conclusion: PRO provides a framework for the formal representation of protein classes and protein
forms in the OBO Foundry. It is designed to enable data retrieval and integration and machine reasoning at
the molecular level of proteins, thereby facilitating cross-species comparisons, pathway analysis, disease
modeling and the generation of new hypotheses.
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Background
Biomedical ontologies are emerging as critical tools in
genomic and proteomic research, where complex data in
disparate resources need to be integrated. The OBO Foun-
dry is a collaborative effort to establish a set of principles
for ontology development with the goal of creating a suite
of orthogonal interoperable reference ontologies in the
biomedical domain [1]. The Foundry ontologies are
organized along two dimensions: (1) granularity (from
molecule to population) and (2) relations to time
(objects, qualities, processes). In this scheme, PRO is a
representation of entities on the level of granularity of
molecules, and interoperates with other ontologies, such
as the Sequence Ontology (SO) [2] and the Gene Ontol-
ogy (GO) [3] which incorporate representations of pro-
tein qualities and processes. PRO encompasses a sub-
ontology of proteins based on evolutionary relatedness
(ProEvo) and a sub-ontology of the multiple protein
forms produced from a given gene (ProForm) [4]. Of two
other ontologies that have been designed for protein data-
base integration or annotation, neither includes represen-
tations of the protein forms themselves. The Protein
Ontology (PO) [5] includes terms and relationships to
describe attributes of individual protein forms (such as
physicochemical properties), while the Proteomics Proc-
ess Ontology (ProPreO) [6] serves the detailed description
of proteomics experimental processes.
Here we summarize the current PRO framework and the
accompanying annotations, basing our account of the use
of the PRO in representating proteins from the TGF-beta
signaling pathway. This pathway is well-studied, and thus
provides a rich body of protein annotations relating to a
wide spectrum of protein forms derived from cleavage
and/or post-translational modifications (PTMs), alterna-
tive splicing, and sequence variants that are related to dis-
ease.
The PRO framework
A detailed description of the PRO framework has been
presented in our previous work [4]. Briefly, the framework
was designed to enable data retrieval and integration, and
machine reasoning at the molecular level of proteins by
means of a structure to support formal, computer-based
inferences of shared attributes among homologous pro-
teins (addressed by ProEvo); and an explicit representa-
tion of the various forms of a given gene product
(addressed by ProForm) [4]. Figure 1 is an outline repre-
sentation of the current version of PRO and of a subset of
its connections to other ontologies. The root in the ontol-
ogy is the class protein, which is defined as "A biological
macromolecule that is composed of amino acids linked in
a linear sequence (a polypeptide chain), and is genetically
encoded". PRO terms are connected by the relationship
is_a or derives_from, both defined in the OBO Relations
Ontology [7]. The framework figure points to levels of dis-
tinction that are "unofficial" descriptors for sets of PRO
classes meant to provide some indication of how PRO is
organized.
ProEvo
Proteins with full-length sequence similarity are said to be
homeomorphic; they are presumed to share a common
ancestor. Within any given homeomorphic group, there
may be monophyletic subgroups of proteins that have dis-
tinct functions [8,9]. ProEvo was designed to define pro-
tein classes on this basis and to capture the relationship
between these classes. Therefore, it includes proteins at
both the family and the gene product levels. In ProEvo,
terms are connected by the is_a relationship.
ProForm
This part of the ontology describes the translational prod-
ucts that are experimentally characterized, and includes
definitions of sequence forms arising from allelic, splice
and translational variation and from PTM and cleavage. It
also includes representations of protein products of fused
genes. Therefore, the coverage domain of ProForm
includes both sequence (isoform and variant) and modi-
fication levels. We use the derives_from  relationship to
describe the relation between a modified form and the
parent protein.
PRO annotation
The generation of protein diversity from a single gene can
make the systematic functional annotation of gene prod-
ucts difficult. Many model organism databases (MODs)
utilize the Gene Ontology (GO) for functional annotation
of gene products. Annotations provided in gene associa-
tion files for each organism are tied to a single object:
gene, transcript or protein. However, most MOD annota-
tions currently default to the level of the gene. Similarly,
most protein annotations in GOA are attached to the
canonical sequence, and in a few cases to the specific iso-
form [10]. PRO defines existing protein objects based on
the current knowledge, allowing annotation at a more
appropriate level (such as isoforms, sequence variants and
post-translationally modified forms). As depicted in Fig-
ure 1, the attributes of each PRO term can be described by
cross-referencing to various ontologies and/or databases
that are pertinent to protein annotation such as GO, SO
and Modification Ontology (PSI-MOD).
Results and discussion
Building the ontology
Here we focus on the set of proteins in the TGF-beta sign-
aling pathway as described in the KEGG pathway database
[11], which consists of three sub-pathways: the TGF-beta
signaling pathway, the bone morphogenetic protein sign-
aling pathway, and the activin-mediated signaling path-BMC Bioinformatics 2009, 10(Suppl 5):S3 http://www.biomedcentral.com/1471-2105/10/S5/S3
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way. It includes reference to 79 human/mouse
orthologous proteins that map to 34 PIRSF [8] homeo-
morphic families and 36 Pfam [12] domains. We applied
an automated process to generate the prospective PRO
nodes, followed by manual curation involving literature
review and further sequence analysis. Each curated node
consists of a PRO ID, a term name, a definition and a
cross-reference (when applicable). The framework allows
the creation of ProForm nodes for newly published,
experimentally-characterized isoforms or sequence vari-
ants, including those not yet represented in sequence
databases (e.g., PRO:000000478 smad5 isoform 2 and
PRO:000000483 smad9 isoform 2). Moreover, it allows
the representation of proteins that are products of a gene
fusion due to chromosomal translocation, such as
PRO:000000091  creb-binding protein/zinc finger protein
HRX that is encoded by part of the CREBBP gene at the N-
terminus and part of the MYST4 gene at the C-terminus.
This form is observed in some cases of acute myelogenous
leukemia.
Figure 2A shows a snapshot of the ontology in OBO edit
with delineation of ProEvo and ProForm for the TGF-beta
1 protein. The important property for each ProForm term
is simply that the protein form has been found to exist in
nature, not how that form came into existence. Thus, PRO
does not take into account the steps leading to a particular
form, and there is no hierarchy indicating that, for exam-
ple, a phosphorylated and ubiquitinated form derived
from an original phosphorylated form–the hierarchy is
flattened so that each term is a sibling of the other. This is
because one cannot assume that the steps leading to a
multiply-modified form always occur in the same order.
PRO annotation
We have created a PRO association file (PAF) to provide
the experimentally-based annotation for the proteins that
are sub-types of a given class. To facilitate the exchange of
annotation between PRO and GO, the PAF adopts the for-
mat of the GO annotation file [13] with some modifica-
tions. For example, each PRO term may contain
annotation derived from other ontologies in addition to
PRO framework Figure 1
PRO framework. Current working model and a subset of the possible connections to other ontologies.
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Ontology for the TGF-beta 1 protein Figure 2
Ontology for the TGF-beta 1 protein. A. Snapshot of the ontology (partial DAG view) in OBO Edit 1.1 including terms 
representing ProEvo and ProForm. Terms in red boxes are described in panel B. B. Detailed example of the ontology and 
annotation displayed together for convenience. The above is a partial view, not all forms are listed, and only key annotations 
are shown.
PRO:000000001 protein
is_a PRO:000000008 TGF-beta-like cysteine-knot cytokine { PIRSF8000009 } 
     def: A protein with a core domain composition consisting of a signal peptide, a variable propeptide region  
      and a transforming growth factor beta like domain, that is a cysteine-knot domain containing four conserved beta strands,  
        S1-S4, which form two antiparallel beta sheets (S1-S2 and S3-S4) interconnected by three disulfide bridges in a knot-like topology.  
            Pfam:PF00019 "has_part Transforming growth factor beta like domain". 
         is_a  PRO:000000046 TGF-beta { PIRSF001787 } 
def: A TGFB-like cysteine-knot cytokine whose propeptide region is a latent associated peptide (LAP) that remains associated  
to the mature TGF-beta after cleavage and secretion, rendering TGF-beta inactive. This is the founding member of the cysteine-
knot cytokine family, and is related to the activin/inhibin, anti-Muellerian hormone, and bone morphogenic protein families, which 
are all involved in the regulation of cell growth and differentiation. 
     is_a PRO:000000182 TGF-beta 1 (TGFB1 gene products) { PANTHER:PTHR11848:SF32 } 
                def: A TGF-beta that is a translation product of the TGFB1 gene. 
       is_a PRO:000000397 TGF-beta 1 isoform 1 (precursor) { UniProtKB: P01137-1, P04202-1 } 
def: A TGF-beta 1 that is a translation product of a mature transcript of the TGFB1 gene, and includes all core domains 
 (signal peptide, latent associated peptide and a transforming growth factor beta like domain). This form is represented by the
human sequence UniProtKB:P01137-1. This form is a precursor. 
GO:0005796 "located_in Golgi lumen [PMID:1544940, TaxID:9606]". 
         derives_from PRO:000000513 TGF-beta 1 isoform 1 cleaved form 
       is_a  PRO:000000616 TGF-beta 1 isoform 1 cleaved 1 (TGF-beta 1 active peptide) { P01137-1 (279-390) }
def: A TGF-beta 1 isoform 1 cleaved form that has been processed by proteolytic cleavage and released from the  
latent complex. This form is the active mature peptide. 
GO:0005160 "has_function transforming growth factor beta receptor binding [PMID:14764882, TaxID:10090]". 
         GO:0005578  "located_in  proteinaceous  extracellular  matrix  [PMID:9008713,  TaxID:10090]". 
         derives_from PRO:000000512 TGF-beta 1 isoform 1 cleaved and glycosylated 
         MOD:00693 "has_modification glycosylated residue".
       is_a PRO:000000617 TGF-beta 1 isoform 1 cleaved and glycosylated 1 (TGF-beta 1 latent peptide) 
       is_a PRO:000000618 TGF-beta 1 isoform 1 cleaved and glycosylated 2 (Latent complex)  
                { P01137-1 (30-279, N-glycosylated Asn-82):(279-390) } 
GO:0005160 "NOT has_function transforming growth factor beta receptor binding [PMID:3162913, TaxID:9606]". 
GO:0005578 "located_in proteinaceous extracellular matrix [PMID:9008713, TaxID:10090]". 
A
B
ProEvo
ProFormBMC Bioinformatics 2009, 10(Suppl 5):S3 http://www.biomedcentral.com/1471-2105/10/S5/S3
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GO. Additional columns were added to account for
sequence coordinate specifications, such as the range of
the sequence (for cleaved form) or the modified resi-
due(s) (for modified form) (Table 1).
PRO applications
The PRO framework provides a basis for more accurate
annotation. This is especially important given the current
growth of experimental data specific to the isoforms and
modified forms. Figure 2 shows the PRO terms related to
the TGF-beta 1 protein together with definitions, relation-
ships and annotations, demonstrating the complexity and
variety of protein classes and sequence forms that can be
derived from a given parent sequence. At the ProEvo level,
the PRO term TGF-beta-like cysteine-knot cytokine is defined
as a protein with a signal peptide, a variable propeptide
region and a cysteine-knot domain (Figure 2B,
PRO:000000008). The class represented by this term has
seven children nodes (Figure 2A), each defined as a sepa-
rate group on the basis of sequence similarity and distinc-
tive functional features. The granularity at this level varies
depending on the sequence and functional diversity of the
protein class. However, a ProEvo leaf node is always rep-
resented by a gene product class, which is defined as all
protein products of orthologous genes. TGF-beta is a child
node of the above-mentioned class and has three leaf
nodes, TGF-beta 1, TGF-beta 2 and TGF-beta 3. In the cur-
rent framework, PRO represents the full-length homeo-
morphic proteins and not the individual domains.
Instead, domain information is included as a cross-refer-
ence to the Pfam domain database [12] in the ontology to
indicate that a given protein class has_part some domain
(Figure 2B, PRO:000000008). At the ProForm level, the
TGF-beta 1 precursor (PRO:000000397) is a dimer and
undergoes cleavages by a signal peptidase and by furin in
the Golgi to generate two functionally important chains:
the TGF-beta 1 mature peptide (PRO:000000616) and the
latent peptide (PRO:000000617). These two chains
remain associated as a latent complex (PRO:000000618)
until proteases in the extracellular space degrade the latent
peptide. In most databases, TGF-beta 1 canonical
sequence (corresponding to the precursor) is annotated
with GO:0005160 transforming growth factor beta recep-
tor binding. ProForm allows this GO term to be appropri-
ately associated with the active mature protein rather than
the precursor. Note that these various forms not only dif-
fer in function but also in their cellular localization.
PRO and cross-species analysis
PRO can facilitate cross-species comparison of protein
forms based on annotations with experimental evidence
and sequence conservation, as illustrated in Figure 3.
Here, PRO:000000655 (smad2 isoform 2 acetylated and
phosphorylated 1) is annotated with GO terms based on
the experimental evidence on the human entry (with the
associated literature and taxon ID) (Figure 3A). Based on
the PRO mapping to UniProtKB, there is a mouse counter-
part for smad2 isoform 2. Since the protein features
(acetylation and phosphorylation sites) are conserved,
(Figure 3B), one can investigate the existence of this mod-
ified form in mouse and its possible regulation by the
coactivators. This analysis is not limited to human and
mouse, since a sequence search using the human isoform
2 as query detects the bovine isoform 2 with high
sequence similarity and a multiple alignment reveals the
conservation of the sequence features covering the modi-
fied sites (Figure 3B). Such cross-specifies comparisons
can provide the basis for the generation of new testable
hypotheses, such as explaining the similarities or differ-
ences in protein function between different taxa due to the
presence or absence of a given modification sites.
PRO and pathway analysis
The PRO curation of the TGF-beta signaling pathway illus-
trates the application of protein ontology in the context of
pathway analysis. The states of a molecule are natural
components of pathway ontologies or databases such as
INOH Event Ontology [14] or Reactome [15]. As biomed-
ical data expand, it will be increasingly important to
explicitly represent these protein forms so that representa-
tions of attributes can be attached to the appropriate enti-
ties. Figure 4 shows the mapping of PRO terms to the
associated Reactome events in the TGF-signaling pathway.
The mapping of the entities involved in the pathway gives
a more accurate and complete framework for researchers
to analyze their data.
PRO and disease modelling
The PRO-pathway mapping supports modeling of the spe-
cific objects involved in a given disease in the pathway
context. For example, it is possible to model cardiac myo-
cyte apoptosis, a process in which activated caspase-3 gen-
erates the cleaved form of rho-associated protein kinase 1
(PRO:000000563). This form is constitutively active and
promotes apoptotic signals, as has been observed both in
the mouse myopathy model and in human heart failure
patients [16,17]. Another example of disease modeling is
the ability to link different protein variants that are asso-
ciated to a common disease. Juvenile polyposis is an auto-
somal dominant syndrome predisposing to colorectal and
gastric cancer. This syndrome is caused by variants of
smad4 or BMP receptor type-1A [18]. Although smad4 is
common to all TGF beta-related signaling pathways, BMP
receptor type-1A is only active in the BMP-signaling sub-
pathway; therefore, this information could potentially
provide a clue for the specific pathway as well as the
molecular mechanism that leads to the observed pheno-
type.BMC Bioinformatics 2009, 10(Suppl 5):S3 http://www.biomedcentral.com/1471-2105/10/S5/S3
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Table 1: Example annotation in the PRO association file (PAF).
PRO_ID Object_term Qual Relation Ontology_ID Ontology_ter
m
Ev.Source 
(PMID)
DB_ID 
(UniProt)
Modified_resi
due, 
MOD_ID
PRO:000000
535
c-myc isoform 1 
acetylated 1
has_function GO:0003700 transcription 
factor activity
16126174 P01106-1 Lys-143/Lys-
157/Lys-275/
Lys-317/Lys-
323/Lys-371, 
MOD:00394
PRO:000000
535
c-myc isoform 1 
acetylated 1
located_in GO:0005634 nucleus 16126174 P01106-1 Lys-143/Lys-
157/Lys-275/
Lys-317/Lys-
323/Lys-371, 
MOD:00394
PRO:000000
535
c-myc isoform 1 
acetylated 1
part_of GO:0005667 transcription 
factor complex
16126174 P01106-1 Lys-143/Lys-
157/Lys-275/
Lys-317/Lys-
323/Lys-371, 
MOD:00394
PRO:000000
535
c-myc isoform 1 
acetylated 1
has_modificati
on
MOD:00394 acetylated 
residue
16126174 P01106-1 Lys-143/Lys-
157/Lys-275/
Lys-317/Lys-
323/Lys-371, 
MOD:00394
PRO:000000
536
c-myc isoform 1 
glycosylated 1
has_function GO:0003700 transcription 
factor activity
11904304 P01106-1 Thr-58, 
MOD:00806
PRO:000000
536
c-myc isoform 1 
glycosylated 1
participates_in GO:0006357 regulation of 
transcription 
from RNA 
polymerase II 
promoter
11904304 P01106-1 Thr-58, 
MOD:00806
PRO:000000
536
c-myc isoform 1 
glycosylated 1
has_modificati
on
MOD:00806 O-(N-
acetylaminoglu
cosyl)-L-
threonine
11904304 P01106-1 Thr-58, 
MOD:00806
PRO:000000
537
c-myc isoform 1 
phosphorylated 1
has_function GO:0003700 transcription 
factor activity
11018017 P01108-1 Ser-62, 
MOD:00046
PRO:000000
537
c-myc isoform 1 
phosphorylated 1
located_in GO:0005634 nucleus 11018017 P01108-1 Ser-62, 
MOD:00046
PRO:000000
537
c-myc isoform 1 
phosphorylated 1
part_of GO:0005667 transcription 
factor complex
11018017 P01108-1 Ser-62, 
MOD:00046
PRO:000000
537
c-myc isoform 1 
phosphorylated 1
participates_in GO:0006357 regulation of 
transcription 
from RNA 
polymerase II 
promoter
11018017 P01108-1 Ser-62, 
MOD:00046
PRO:000000
537
c-myc isoform 1 
phosphorylated 1
participates_in GO:0008283 cell 
proliferation
11018017 P01108-1 Ser-62, 
MOD:00046
PRO:000000
537
c-myc isoform 1 
phosphorylated 1
participates_in GO:0055072 iron ion 
homeostasis
11018017 P01108-1 Ser-62, 
MOD:00046
PRO:000000
537
c-myc isoform 1 
phosphorylated 1
has_modificati
on
MOD:00046 O-phospho-L-
serine
11018017 P01108-1 Ser-62, 
MOD:00046
PRO:000000
538
c-myc isoform 1 
phosphorylated 2
NOT has_function GO:0003700 transcription 
factor activity
7623799 P01106-1 Ser-62, 
MOD:00046|T
hr-58, 
MOD:00047
PRO:000000
538
c-myc isoform 1 
phosphorylated 2
located_in GO:0005634 nucleus 14563837 P01108-1 Ser-62, 
MOD:00046|T
hr-58, 
MOD:00047
PRO:000000
538
c-myc isoform 1 
phosphorylated 2
has_modificati
on
MOD:00046 O-phospho-L-
serine
14563837 P01108-1 Ser-62, 
MOD:00046|T
hr-58, 
MOD:00047BMC Bioinformatics 2009, 10(Suppl 5):S3 http://www.biomedcentral.com/1471-2105/10/S5/S3
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PRO and GO Complex
The GO Cellular Component includes protein complexes,
which are defined in many cases on the basis of their com-
ponent proteins. GO terms are species-neutral, as are the
protein classes in PRO. PRO provides a means for creating
the corresponding logical definitions in the GO complex
ontology by using the precise PRO term that describes the
form (modified or isoform) that occurs in the complex.
Therefore, a GO complex can be defined as X complex
has_part PRO1, has_part PRO2....has_part PROn.
PRO and Cell Ontology
PRO also provides protein terms to Cell Ontology. Masci
and collaborators have recently proposed to define some
dentritic cell types (DC-CL) in terms of the proteins and
protein complexes expressed on the cell surface by relating
terms in DC-CL to terms for proteins in the PRO and to
terms for protein complexes in GO [19].
PRO dissemination and statistics
The PRO ontology file (in OBO format) and the PAF
annotation file (in tab-delimited format) are dissemi-
nated through the PRO website [20], the OBO Foundry
[21] and the National Center for Biomedical Ontology
(NCBO) BioPortal [22]. PRO can be also downloaded in
formats other than OBO such as OWL from the OBO
Foundry [21]. Table 2 summarizes the release statistics
with the total numbers of protein and PRO terms, which
cover the TGF-beta signaling-related proteins (release
1.0), additional voltage-gated channel proteins as part of
an ongoing collaboration with the Neuroscience Informa-
tion Framework project [23] (release 2.0), and additional
immunology-related proteins as part of the collaboration
with the DC-CL project (current release 3.0). In the cur-
rent PAF file, there are about 2350 annotations, covering
499 GO terms, and 1860 PMIDs. Table 3 provides more
detailed statistics pertaining to the annotation of GO, PSI-
MOD and SO terms.
Ongoing developments
One of the aims of the PRO consortium is to engage the
biological community in the curation of the ontology and
annotation. Thus, it is key to have a web-based editor that
fulfils the requirement of a single interface for the curation
of the ontology and annotation and that provides links to
external resources and tools that will facilitate the cura-
tion task. A web-based ontology and annotation editor is
under development and has been initially tested for com-
munity annotation during an annotation jamboree held
in November, 2008, along with the PRO annual meeting.
Based on the feedback, we are now enhancing the features
and functionality of the editor. To maximize ontology
usage, a web-based search interface will be developed that
retrieves information from both the ontology and the
annotation. This search interface will permit searching of
the ontology and the annotation, plus other external
links. Special functions will include: finding the equiva-
lent isoforms (ortho-isoforms) in human and mouse, and
the accompanying annotation; searching for the modified
forms of a given protein that are non functional (with
NOT has_function annotation); and searching for protein
classes sharing a given domain.
Conclusion
We have illustrated key aspects of the PRO framework
through reference to proteins involved in the TGF-beta
signaling pathway. The significance of the Protein Ontol-
ogy is multi-fold: (1) ProEvo provides a structure to sup-
port formal, computer-based inferences based on shared
attributes among homologous proteins; (2) ProForm
helps to delineate the multiple protein forms of a gene;
(3) PRO provides critical interconnections between exist-
ing OBO Foundry ontologies; (4) PRO can be integrated
with or cross-referenced by other ontologies and/or data-
bases, as for example, to better define objects in pathways
or complexes or in disease modeling; and (5) the PRO
framework allows the community to annotate proteins of
interest. In summary, PRO offers a comprehensive picture
of the protein realm by connecting protein evolution,
PRO:000000
538
c-myc isoform 1 
phosphorylated 2
has_modificati
on
MOD:00047 O-phospho-L-
threonine
14563837 P01108-1 Ser-62, 
MOD:00046|T
hr-58, 
MOD:00047
PRO:000000
539
c-myc isoform 1 
phosphorylated 3
located_in GO:0005634 nucleus 12676581 P01106-1 Ser-62/Ser-71, 
MOD:00046
PRO:000000
539
c-myc isoform 1 
phosphorylated 3
participates_in GO:0045766 positive 
regulation of 
angiogenesis
12676581 P01106-1 Ser-62/Ser-71, 
MOD:00046
PRO:000000
539
c-myc isoform 1 
phosphorylated 3
has_modificati
on
MOD:00046 O-phospho-L-
serine
12676581 P01106-1 Ser-62/Ser-71, 
MOD:00046
PRO:000000
480
smad6 isoform 2 NOT has_part Pfam:PF03165 MH1 domain 11284962 O43541-2
Selected columns are shown. Note that the last two columns are a tuple that define the sub-type of the class.
Table 1: Example annotation in the PRO association file (PAF). (Continued)BMC Bioinformatics 2009, 10(Suppl 5):S3 http://www.biomedcentral.com/1471-2105/10/S5/S3
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function, modification, variants and disease. Finally, PRO
can be adopted where data integration at the molecular
level of proteins is needed, such as in systems biology or
translational medicine.
Methods
Automated generation of PRO nodes
An automated process has been developed to generate
preliminary PRO nodes (PrePRO) from PIR databases
(PIRSF and iProClass [24]), UniProtKB [25], PANTHER
[9] and MGI [26]. The automated process includes the fol-
lowing steps:
1. Retrieve all human and mouse proteins from Uni-
ProtKB.
2. Obtain splice and genetic variant nodes from the
UniProtKB Features field.
3. Obtain orthologous relationship between mouse
and human genes from MGI sources.
4. Obtain orthologous relationship between isoforms
of mouse and human orthologous genes based on all-
against-all BLAST alignment results.
5. Group orthologous genes according to PANTHER
and/or PIRSF if applicable.
6. Extract PTMs and GO information from iProClass
and literature sections of UniProtKB.
7. Arrange obtained information according to PRO
framework.
Due to the dynamic nature of these data sources, we
record the versioning of the sources to ensure accurate
relationships of the mapping during PRO curation. Pre-
PRO can be generated in both batch mode and interac-
tively for a list of proteins to capture up-to-date
information in the data sources. Each node is assigned a
unique PrePRO ID. After curation a stable PRO ID is gen-
erated. The computationally-generated file is in OBO for-
mat, and OBO Edit 1.1 [27] has been used as the curation
platform.
Manual curation of PRO terms
Manual curation is needed because the PrePRO terms rep-
resent the protein entities and relationships as they are
presented in the databases rather than representing the
actual protein entities and their relationships. Curation
PRO for cross-species comparison Figure 3
PRO for cross-species comparison. A. Ontology and annotation for smad2 isoform 2 protein. B. Multiple sequence align-
ment of the N- and C-termini of smad2 protein isoform 2 orthologs containing the modified sites.
UniProtKB Ac SSxS motif Organism
bovine
mouse
human
Conserved Lys UniProtKB Ac SSxS motif Organism
bovine
mouse
human
Conserved Lys
B
A
PRO:000000469 smad2 isoform 2 (Maps to: UniProtKB:Q62432-2, Q15796-2 )
derives_from PRO:000000575 smad2 isoform 2 acetylated and phosphorylated
is_a PRO:000000655 smad2 isoform 2 acetylated and phosphorylated 1
(Phosphorylated in the last two Ser residues within the SSxS C-terminal motif by TGF-beta
pathway activation and acetylated in a Lys residue within the MH1 domain by coactivators, 
such as CBP, PCAF and EP300).
Annotation available for PRO:000000655 :
GO:0003677 "has_function DNA binding [PMID:17074756, TaxID:9606]".
GO:0003713 "has_function (increased) transcription coactivator activity [PMID:17074756, TaxID:9606]".
GO:0007179 "participates_in transforming growth factor beta receptor signaling pathway [PMID:17074756, TaxID:9606]".
MOD:00046 "has_modification O-phosphorylated L-serine [Q15796-2:Ser-435/Ser-437, TaxID:9606] ".
MOD:00394 "has_modification acetylated residue [Q15796-2:Lys-19, TaxID:9606]".BMC Bioinformatics 2009, 10(Suppl 5):S3 http://www.biomedcentral.com/1471-2105/10/S5/S3
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involves (i) merging of nodes, for example where PIRSF
and PANTHER families represent the same homeomor-
phic protein class, and (ii) creation of the protein forms
after reviewing the literature and performing sequence
analysis, for example to analyze what combination of
modifications occurs in a specific form, and to determine
what forms are equivalent in mouse and human (in the
future potentially also in other organisms). In ProForm,
the translation products originating from different mature
transcripts of a gene or from the use of alternative initia-
tion translation sites are referred to as isoforms. Equiva-
lent isoforms in different organisms are collapsed into a
single node. This assignment is based primarily on evi-
dence in the literature and on protein sequence analysis.
Genetic variants, including deletions/insertions and sin-
gle nucleotide polymorphisms, are referred by PRO to as
sequence variants. Isoforms are created based on the alter-
native product section of the UniProtKB entry, and vari-
ants (only for human entries) are created from the Seq_var
field information. Only variants related to disease are
included in the current version of the PRO. The final
curated ProForm terms are based on experimentally
observed entities, i.e., a type is added to the ontology only
when there is at least one characterized sub-type.
PRO mapping to the Reactome TGF-beta signaling pathway Figure 4
PRO mapping to the Reactome TGF-beta signaling pathway. The pathway described herein corresponds to 
REACT_6844. Each step in the pathway is described by a Reactome event ID. Bold PRO IDs indicate objects that undergo 
some modification that is relevant for function (the modified form is underlined). The names in the boxes represent the names 
of the complexes or molecules involved in the processes, not of the PRO terms.
Smad 4
P
10
8
9
Nucleus Cytoplasm
PRO:000000616; 
PRO:000000409;
PRO:000000522
Complex with receptor 
type I
Smad 2
Smad 2
SARA
PRO:000000616;
PRO:000000409;
PRO:000000523;
Receptor I 
phosphorylated
P
PRO:000000616; 
PRO:000000409;
PRO:000000523;
PRO:000000313;
PRO:000000468;
Receptor complex with 
SARA and Smad2
Smad 2
SARA P
P
PRO:000000616; 
PRO:000000409;
PRO:000000523;
PRO:000000313;
PRO:000000650
Smad2 Phosphorylated (by 
receptor complex)
Smad 2
P Smad 4
REACT_6888.1
2
REACT_6872.1
3
REACT_6945.1 4
5 6
7
Smad 2
Smad 4
P
Smad 2
P
Transc factors
Smad 2
Smad 4
P
PRO:000000650;
PRO:000000366
PRO:000000366
PRO:000000650
PRO:000000468
PRO:000000616
TGF-beta1 active form
PRO:000000618;
PRO:000000552
Large latent complex
PRO:000000409;
PRO:000000616
TGF-beta1 active 
form bound to 
receptor type II
PRO:000000650;
PRO:000000366
R-Smad/Co-Smad 
complex
Smad2/Smad4 complex binding 
to other transcription factors to 
start transcription
REACT_6816.1
REACT_6923.1
REACT_6979.1
REACT_6760.1
REACT_6726.1
1
Table 2: Statistics on Protein Ontology releases. PRO ontology 
coverage of proteins, and ProEvo and ProForm terms
Number of Pro.obo Releases
1.0 2.0 3.0
Proteins 79 149 289
PRO terms 667 1023 1269
ProEvo terms 119 223 397
ProForm terms 548 800 872BMC Bioinformatics 2009, 10(Suppl 5):S3 http://www.biomedcentral.com/1471-2105/10/S5/S3
Page 10 of 11
(page number not for citation purposes)
Curation of PRO names
All PRO term names are lower case except for certain
standard abbreviations such as DNA, ATP, and GTP. These
names are based on naming guidelines provided by
nomenclature committees, literature, and UniProtKB
[28], and the OBO Foundry [29], among others. The
name used for a ProForm term is based on its parent node
(see examples in Figure 2A).
PRO definitions
All PRO terms have a definition that conforms to OBO
foundry standards (see examples in Figure 2B). Whenever
possible, the ProEvo definitions on the family level follow
the form "A parent term with a core domain composition
consisting of domain 1, domain 2...." with reference to con-
served motifs and domain regions; in many cases exam-
ples are supplied. For example, PRO:000000026 smad
anchor for receptor activation is defined as "A protein
with a core domain composition consisting of a FYVE
domain and a smad-binding domain that is involved in
recruiting and presenting receptor-regulated smads to the
receptor complex." [30]
Each PRO definition has source attribution to PubMed
ID, PRO curator initials, or other resource ID. At the gene
product level, the definition follows the format "A parent
term  that is a translation product of the GENE NAME
gene." For example, PRO:000000125 sara is defined as: "A
smad anchor for receptor activation that is a translation
product of the ZFYVE9 gene." [PRO:CNA]
In many cases additional information is added. The
reviewed section of UniProtKB contains curated gene
names, providing standardization at least within certain
taxon groups (e.g., within mammals, plants, fungi,
prokaryotes). Within mammals, the human gene name is
the reference for the gene name in PRO definitions, and
other alternative names are added as synonyms. The defi-
nitions of isoforms follow the form "A parent name that is
a translation product of a mature transcript of the GENE
NAME  gene. This form is represented by the taxon
sequence UniProtKB:AC-#.", where "mature transcript" is
a term defined by the Sequence Ontology (SO:0000233).
Whenever possible, additional information about the
presence or absence of domains or motifs is included as
part of the definition. For example PRO:000000315 sara
isoform 3 is defined as: "A sara that is a translation prod-
uct of the mature transcript of ZFYVE9 gene, and lacks the
smad-binding domain. This form is represented by the
human sequence UniProtKB:O95405-3." [PRO:CNA]
PRO annotations
The annotation to the PRO terms was done according to
PAF formatting guidelines [31] and the GO Annotation
Guide [32].
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Ontology OBO Relation # Terms* Example
GO Molecular Function has_function 295 PRO:000000650 smad 5 isoform 1 
phosphorylated 1
GO:0046332 SMAD binding
NOT has_function 55 PRO:000000478 smad 5 isoform 2 GO:0046332 SMAD binding
GO Cellular Component Complex part_of 62 PRO:000000178 RING-box protein 
2 isoform 1
GO:0000151 ubiquitin ligase 
complex
NOT part_of 5 PRO:000000179 RING-box protein 
2 isoform 2
GO:0000151 ubiquitin ligase 
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GO Cellular Component located_in 240 PRO:000000457 noggin isoform 1 
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